Actinogen Medical Valuation
| ATGGF Stock | USD 0.03 0.00 0.00% |
Actinogen Medical seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Actinogen Medical from analyzing the firm fundamentals such as Return On Equity of -0.48, current valuation of 125.91 M, and Profit Margin of (2.61) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Actinogen Medical's price fluctuation is out of control at this time. Calculation of the real value of Actinogen Medical is based on 3 months time horizon. Increasing Actinogen Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Actinogen pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Actinogen Medical Limited. Since Actinogen Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Actinogen Pink Sheet. However, Actinogen Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0311 | Real 0.0278 | Hype 0.03 |
The real value of Actinogen Pink Sheet, also known as its intrinsic value, is the underlying worth of Actinogen Medical Company, which is reflected in its stock price. It is based on Actinogen Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Actinogen Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Actinogen Medical Limited helps investors to forecast how Actinogen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Actinogen Medical more accurately as focusing exclusively on Actinogen Medical's fundamentals will not take into account other important factors: About Actinogen Medical Valuation
The pink sheet valuation mechanism determines Actinogen Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Actinogen Medical. We calculate exposure to Actinogen Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Actinogen Medical's related companies.Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological, psychiatric, and metabolic diseases in Australia. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Actinogen Med operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Actinogen Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Actinogen Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Actinogen Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Actinogen Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Actinogen Medical's revenue streams: Identify Actinogen Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Actinogen Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Actinogen Medical's growth potential: Evaluate Actinogen Medical's management, business model, and growth potential.
- Determine Actinogen Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Actinogen Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Actinogen Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Actinogen Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.8 B | |
| Retained Earnings | -57.9 M |
Complementary Tools for Actinogen Pink Sheet analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |